Tiny Cup Attached to Eye Improves Drug Delivery For Retinal Diseases
With preliminary testing complete, Dr. Murphree is currently developing a protocol for Phase I/II clinical trials in humans to take place over the coming
Founded in 1928 with 12,000 members currently, ARVO is one of the nation's largest organizations for research in vision and ophthalmology...
Economy is Driving Many Osteoporotic Women to Retire Later - But Their Ability to Work May Be Undermined by Sub-Optimal Management of Their Disease
...ot optimally managing their osteoporosis.
"It concerns me that the number of Ohioans who will suffer from osteoporosis will only grow in the coming
decade, but it is more concerning that women suffering from the disease today are not optimally managing their bone health," said Chad Deal, M.D., Hea...
Schering-Plough Announces U.S. Filing of Mometasone Furoate/Formoterol Fumarate Combination for the Maintenance Treatment of Asthma
...aintness). If you or your child is under stress, such as with surgery, after surgery, or trauma, you may need steroids by mouth again.
in contact with measles, chicken pox virus, tuberculosis, or any other infections before or while using ASMANEX. Contact your health care provider imm...
Idenix Pharmaceuticals Successfully Completes Proof-of-Concept Study of IDX184 for the Treatment of Hepatitis C Virus (HCV)
...cer of Idenix. "With the successful completion of the proof-of-concept study for IDX184 and plans to file investigational new drug applications in the coming
months from our non-nucleoside polymerase inhibitor and protease inhibitor programs, we are closer to achieving our ultimate goal of developing novel ...
Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference
...r's, that is now being used widely in clinical practice. Millions of people can be classified as having MCI, and these numbers are expected to rise in coming
years. Researchers found that neurologists regularly see and treat people with MCI, despite the fact that the medications they are prescribing are not...
Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets
... in 2000, The Michael J. Fox Foundation for Parkinson's Research is dedicated to ensuring the development of a cure for Parkinson's disease within the coming
decade through an aggressively funded research agenda. The Foundation has funded over $145 million in research to date.
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
...activity. Urocidin is formulated for the treatment of bladder cancer, where it is administered by trans-urethral catheter directly into the bladder, coming
into contact with immune system cells and bladder cancer cells. Industry Canada's Industrial Technologies Office (formerly Technology Partnerships Can...
ASMANEX(R) (Mometasone Furoate Dry Powder Inhaler) Now Approved in Japan for the Treatment of Bronchial Asthma in Adult Patients
... or faintness). If you or your child is under stress, such as with surgery, after surgery, or trauma, you may need steroids by mouth again.
in contact with measles, chicken pox virus, tuberculosis, or any other infections before or while using ASMANEX. Contact your health care provider imm...
Why Do African-Americans Fare Worse With Cancer? Access and Economics Are Only Part of the Story
... amplified by another recent study in the Journal of Clinical Oncology . It predicts the cancer incidence among minorities will nearly double in the coming
decades, increasing 99% by 2030 compared to an expected 31% increase among whites.
And the American Society of Clinical Oncology, the field's pre...
Acute Lymphoblastic Leukemia, the Most Common Childhood Cancer, Is Curable Without Preventive Cranial Radiation
...adiation, but they will have a better quality of life because of the absence of its side effects," Pui said.
"In a way, these findings represent coming
full circle," said Dr. William Evans, St. Jude director and CEO and a co-author of the paper. "St. Jude was the first to introduce cranial radiation a...
Brain Fitness Makes Boomers Age Younger
...t Science, the leading provider of brain fitness software , addressed that gathering of venture capitalist and entrepreneurs who are focused on the coming
wave of older consumers. Zimman spoke about "go to market" strategies and said that his company was building the new field of brain fitness by establi...
Ethicon Endo-Surgery Studies Presented at DDW Demonstrate Potential of Pure NOTES Surgery With Company's Toolbox
...thicon Endo-Surgery devices presented in April at the 2009 Society of American Gastrointestinal and Endoscopic Surgeons (SAGES) Annual Meeting. In the coming
months, the Ethicon Endo-Surgery Toolbox for natural orifice surgery will be evaluated in a human clinical trial under an investigational device exemp...
New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
Lived in a region where certain fungal infections like histoplasmosis or coccidioidomycosis are common.
An infection that keeps coming
back (or any problems that increase the risk of infection) or have diabetes.
Any type of cancer or a risk factor for developing cancer, for ex...
Back to Normal: Surgery Improves Outcomes for Spine Patients
...d treatment choice," said Weinstein.
SPORT investigators will be releasing additional studies focusing on cost-effectiveness and other factors in coming
* Degenerative spondylolisthesis occurs when laxness in the spine causes one vertebra to slide forward and press against nerves, caus...
Spirus Medical Announces Complete Examinations of the Small Intestine by Physicians Using Endo-Ease(TM)
...l enteroscopy allows for rapid small bowel access which can give the physician the ability to diagnosis and treat immediately, rather than the patient coming
back for a second endoscopic and/or surgical procedure.
Recently, a pan-endoscopy was completed under conscious sedation by Dr. Stephen Hughes at...
American Lung Association Offers Simple Tips to Protect Public Health and Minimize H1N1 Flu (Swine Flu) and Seasonal Flu Transmission
...conds. Consider singing the "Happy Birthday" song twice in your head to ensure hands are scrubbed long enough. Hands should be dried thoroughly before coming
in contact with anything such as door knobs and even the faucet.
Carrying an alcohol based hand sanitizer is a useful alternative to hand washing...
Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
...als to complete patient enrollment," said Steven W. King, president and CEO of Peregrine. "We will continue to assess patients in this study over the coming
months and look forward to reporting updated preliminary results from the trial at the upcoming ASCO Annual Meeting."
In this trial's Simon two-s...
invivodata Certified to Deliver EXACT in COPD Trials
...ing. COPD is the fourth leading cause of death in the world, and further increases in the prevalence and mortality of the disease are predicted in the coming
decades (Source: www.who.int ). In the United States 11.4 million Americans are diagnosed with the disease with over 122,000 deaths each year. Clin...
Peregrine Pharmaceuticals Reports Positive Preliminary Data From Phase II Bavituximab Lung Cancer Trial
...th the goal of completing patient enrollment around mid-year. We intend to provide further updates as patient treatment and follow-up continue in the coming
The primary objective of the multi-center, open-label Phase II study is to assess the overall response rate to bavituximab with carbopl...
New Australian Drug Holds Hope of Major Breakthrough in Treating Terminal Blood Cancers
"If we continue to be successful in the current multiple myeloma trial, we expect to be able to move into other types of blood cancer in the coming
year," Mr. Liddle said.
For further information, please contact:
Dr. Rosanne Dunn - +61 2 9514 4060
Alan Liddle - +61 2 9514 7437
NewCardio Leadership to Present Two Abstracts at ISCE Conference
...cuss our novel technology with recognized industry leaders in attendance, and explore the various applications we will be aggressively pursuing in the coming
months and years."
About NewCardio, Inc.
NewCardio is a cardiac diagnostic and services company focused on the development of a proprietar...
Astrocytes Help Separate Man From Mouse
...as of neuroscience is that astrocytes are support cells that don't do much themselves," said Oberheim. "The view is slow to change, but scientists are coming
around. Astrocytes are now acknowledged as active participants in brain function and sensory processing."
The brain's two signaling systems - one...
InnoCentive and Nature Publishing Group Announce Partnership to Facilitate Open Innovation
...wn as 'Solvers') to solve for financial reward. NPG and InnoCentive intend to jointly produce an online platform for open innovation challenges in the coming
months, to facilitate the participation of NPG's large expert audience.
"NPG's flagship journal Nature has for nearly 150 years been at the for...
SGO and ACOG Announce Breast Cancer Fellowship Program for Gynecologic Oncologists
...ely grateful to ACOG for recognizing this important educational need. Together, we are confident this program will improve women's cancer care in the coming
"Breast cancer is the second leading cause of cancer death in US women. One out of every seven women will develop breast cancer in her l...
Pharmaxis Announces New Drug Application Submission for Aridol(TM)
... the development of safe and effective products to help people living with lung diseases, and we look forward to working closely with the FDA over the coming
Asthma affects more than 34 million people in the U.S.(1) with an annual economic cost in the U.S. of $19.7 billion(1) and has a substan...
Beating Blood Clots after Joint Replacement
...understanding among patients is key
LAS VEGAS, Feb. 26 /PRNewswire-USNewswire/ -- As the number of hip and knee replacements skyrocket into the coming
years, patients and orthopaedic surgeons need to work together to evaluate and assess a potentially fatal complication -- blood clots. According to f...
Gallbladder Removal Through Vagina Offers Minimally Invasive Alternative
...h both the mouth and vagina, and will begin utilizing NOTES for a broader range of applications, including appendix removal through the vagina, in the coming
For more information visit www.nmh.org .
About Northwestern Memorial Hospital
Northwestern Memorial Hospital ...
Impact Medical Solutions Announces Initiation of Pilot Clinical Trial and Listing on Frankfurt Stock Exchange
...PR System in North America, the European Union and other important markets." The Company stated that it plans on expanding the current trial over the coming
months to include one or more centers in order to maximize subject enrollment.
The Company is also pleased to announce that its common shares h...
American Heart Association EMS Survey Uncovers Deficiencies in Response, Treatment and Transfer of Patients With Most Deadly Heart Attacks
...drugs if it can be achieved within 90 minutes. EMS is a critical part of the system of care to decrease time to treatment for STEMI patients.
months, the association's staff will receive survey data for their state or region and share it with coalitions composed of EMS and hospital personnel...
MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series
...d dressing when wounds do not heal within 3-4 weeks of treatment with basic standard wound dressings. As was the case with the recent patient profile coming
out of North Shore Long Island Jewish Hospital, these patients' quality of life can be improved tremendously if their wounds healed more quickly."
AGA Medical Corporation Launches Web-Based Stroke Education and Awareness Program Featuring Professional Football Player Tedy Bruschi
... 700,000 Americans suffer from a stroke. One-third of stroke victims are under 65, and even children can suffer a stroke.
About Tedy Bruschi
off the success of winning his 3rd league championship and playing in the annual league all-star game in February of 2005, Tedy unexpectedly experienc...
DNA Therapeutics Closes 2.2 Million EUR Series A Financing Round
...res interests in the firms which
it accompanied through the set-up stage in order to develop and increase the
value of innovative therapeutic projects coming
mainly from academic research
in France, Switzerland and Italy. SGAM SEFTI investment is focused in target
companies at an initial stage of developmen...
Modigene Announces Positive Results of Pilot Toxicity Study of Its Long-Acting Human Growth Hormone hGH-CTP
... dosing frequency in humans."
Dr. Havron added, "We look forward to completing these toxicology studies and finalizing the IND for hGH-CTP in the coming
months. We are pleased too that our current cash resources should enable us to complete the hGH-CTP Phase I clinical program and continue into Phase ...
Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Positive Results of Phase III Study of Milnacipran for the Management of Fibromyalgia
... improvement in pain, patient global impression of change, and physical functioning. Comprehensive analyses of the study data will be completed in the coming
weeks, and it is anticipated that further results will be presented during 2009.
Enobia Initiates Infantile Enzyme Replacement Trial for Rare Bone Disease
...e continue to enroll patients in our adult Phase I study and will be treating other pediatric patients from North American and around the world in the coming
The adult male who was initially enrolled in Phase 1 of the trial -- designed to demonstrate the drug's safety -- as well as two oth...
Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows
...s site MedPage Today LLC ( www.MedPageToday.com ).
(Photo: http://www.newscom.com/cgi-bin/prnh/20081125/NY48420 )
While the news coming
out of the American Heart Association (AHA) Scientific Sessions on JUPITER was dramatic, respondents voted 60% to 40% against automatically prescribin...
Arthritis Advisory Committee Recommends FDA Approval of Febuxostat for the Treatment of Hyperuricemia in Patients With Gout
...met treatment needs, and we believe febuxostat will represent an important new option for patients who suffer the debilitating effects of gout. In the coming
months, we will work with the FDA to complete their review, including the design of post-marketing studies."
Febuxostat is a potent non-purin...
NicOx Announces Favorable Blood Pressure Data for Naproxcinod in a Large ABPM Study
...s clear differentiation from naproxen. We are confident that
naproxcinod's potential will be confirmed by the further clinical results
expected in the coming
The three doses of naproxcinod showed good general safety and
tolerability. In the naproxcinod arm 32 patients (54.2%) experienced one or
Michael J. Fox Foundation Announces $11 Million in 2009 Funding for Translational, Pre-Clinical and Clinical Parkinson's Disease Research
...pplication deadline. Date
and time details for each conference call are available at
Additional research funds for the coming
year will be announced at
later dates under the Foundation's 2009 Critical Challenges initiatives --
programs that provide funding for top MJFF resear...
First Town Hall Meeting on Inequities in Clinical Trials to Take Place at the Harlem Hospital Center on October 20
...al Cancer Council (ICC), working to eliminate the
unequal burden of cancer among racial and ethnic minorities and medically
at a time when less than one percent of the entire U.S.
population -- or an estimated 2.3 million Americans -- takes part in the
80,000 medical resear...